Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome

被引:69
作者
Montgomery, RA
Geraghty, MT
Bull, E
Gelb, BD
Johnson, M
McIntosh, I
Francomano, CA
Dietz, HC
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA
[6] Mt Sinai Hosp, Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA
[7] Mt Sinai Hosp, Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
[8] Nat Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD USA
关键词
D O I
10.1086/302144
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mutations in the FBN1 gene, which encodes fibrillin-1, cause Marfan syndrome (MFS) and have been associated with a wide range of milder, overlap phenotypes. The factors that modulate phenotypic severity, both between and within families, remain to be determined. This study examines the relationship between the FBN1 genotype and phenotype in families with extremely mild phenotypes and in those that show striking clinical variation among apparently affected individuals. In one family, clinically similar but etiologically distinct disorders are segregating independently. In another, somatic mosaicism for a mutant FBN1 allele is associated with subdiagnostic manifestations, whereas germ-line transmission of the identical mutation causes severe and rapidly progressive disease. A third family cosegregates mild mitral valve prolapse syndrome with a mutation in FBN1 that can be functionally distinguished from those associated with the classic MFS phenotype. These data have immediate relevance for the diagnostic and prognostic counseling of patients and their family members.
引用
收藏
页码:1703 / 1711
页数:9
相关论文
共 30 条
[21]   A MOLECULAR APPROACH TO THE STRATIFICATION OF CARDIOVASCULAR RISK IN FAMILIES WITH MARFANS-SYNDROME [J].
PEREIRA, L ;
LEVRAN, O ;
RAMIREZ, F ;
LYNCH, JR ;
SYKES, B ;
PYERITZ, RE ;
DIETZ, HC .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (03) :148-153
[22]   Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome [J].
Pereira, L ;
Andrikopoulos, K ;
Tian, J ;
Lee, SY ;
Keene, DR ;
Ono, R ;
Reinhardt, DP ;
Sakai, LY ;
Biery, NJ ;
Bunton, T ;
Dietz, HC ;
Ramirez, F .
NATURE GENETICS, 1997, 17 (02) :218-222
[23]  
Pyeritz Reed E., 1993, P437
[24]   Calcium stabilizes fibrillin-1 against proteolytic degradation [J].
Reinhardt, DP ;
Ono, RN ;
Sakai, LY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :1231-1236
[25]   Calcium determines the shape of fibrillin [J].
Reinhardt, DP ;
Mechling, DE ;
Boswell, BA ;
Keene, DR ;
Sakai, LY ;
Bachinger, HP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) :7368-7373
[26]   FIBRILLIN, A NEW 350-KD GLYCOPROTEIN, IS A COMPONENT OF EXTRACELLULAR MICROFIBRILS [J].
SAKAI, LY ;
KEENE, DR ;
ENGVALL, E .
JOURNAL OF CELL BIOLOGY, 1986, 103 (06) :2499-2509
[27]  
SELANDERSUNNERHAGEN M, 1992, J BIOL CHEM, V267, P19642
[28]   SEQUENCE OF THE CODING REGION OF THE BOVINE FIBRILLIN CDNA AND LOCALIZATION TO BOVINE CHROMOSOME-10 [J].
TILSTRA, DJ ;
LI, L ;
POTTER, KA ;
WOMACK, J ;
BYERS, PH .
GENOMICS, 1994, 23 (02) :480-485
[29]   FIBRILLIN DOMAIN FOLDING AND CALCIUM-BINDING - SIGNIFICANCE TO MARFAN-SYNDROME [J].
WU, YS ;
BEVILACQUA, VLH ;
BERG, JM .
CHEMISTRY & BIOLOGY, 1995, 2 (02) :91-97
[30]   PRIMARY STRUCTURE AND DEVELOPMENTAL EXPRESSION OF FBN-1, THE MOUSE FIBRILLIN GENE [J].
YIN, WS ;
SMILEY, E ;
GERMILLER, J ;
SANGUINETI, C ;
LAWTON, T ;
PEREIRA, L ;
RAMIREZ, F ;
BONADIO, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (04) :1798-1806